Colgate-Palmolive grants COO 31.8K stock options

Colgate-Palmolive’s COO received new stock options and restricted stock units as part of incentive compensation, increasing his direct and indirect equity holdings.

Rhea-AI Filing Summary

COLGATE PALMOLIVE CO (CL) reports that Chief Operating Officer Panagiotis Tsourapas received equity awards on September 16, 2026. He was granted 31,814 stock options to buy common stock at an exercise price of $87.02 per share, expiring on September 16, 2036, vesting in one-third increments beginning on the first anniversary of the grant date.

He also received a restricted stock unit award of 4,597 units of common stock, vesting in equal one-third installments on each of the first, second and third anniversaries of the grant. After these awards, he holds 11,447 shares of common stock directly, plus 4,619 shares held through the issuer’s 401(k) plan trustee and 64,901 shares held indirectly through a trust. No Rule 10b5-1 trading plan is reported for these awards.

Insider Trade Summary

Grant/Award: 36,411 shares

Grant/Award 4 txns

Insider Tsourapas Panagiotis

Role COO, CD, EMEA, APac, Skin

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy) F2, F3	31,814	$0.00	$0.00
Grant/Award	Common Stock F1	4,597	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 31,814 contracts (Direct); Common Stock — 11,447 shares (Direct); Common Stock — 4,619 shares (Indirect, By Issuer's 401(k) Plan Trustee); Common Stock — 64,901 shares (Indirect, By Trust)

Footnotes (3)

1. F1. Restricted stock unit award granted under the issuer's incentive compensation plan. The restricted stock unit award vests in equal 1/3 installments on each of the first, second and third anniversary of the date of grant.
2. F2. Stock option award granted under the issuer's incentive compensation plan.
3. F3. Option becomes exercisable in one-third increments beginning on the first anniversary of the September 16, 2026 grant date.

Key Figures

Stock options granted: 31,814 options Stock option exercise price: $87.02 per share Stock option expiration: September 16, 2036 +4 more

7 metrics

Stock options granted 31,814 options Grant to COO on September 16, 2026

Stock option exercise price $87.02 per share Exercise price for 31,814 stock options granted September 16, 2026

Stock option expiration September 16, 2036 Expiration date of options granted to COO

Restricted stock units granted 4,597 units Restricted stock unit award on September 16, 2026

Direct common shares held 11,447 shares Direct common stock ownership after reported awards

401(k) plan holdings 4,619 shares Common stock held through issuer’s 401(k) plan trustee

Trust holdings 64,901 shares Common stock held indirectly through a trust

Key Terms

restricted stock unit, incentive compensation plan, 401(k) Plan, stock option

4 terms

restricted stock unit financial

"Restricted stock unit award granted under the issuer's incentive compensation plan."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

incentive compensation plan financial

"Stock option award granted under the issuer's incentive compensation plan."

An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.

401(k) Plan financial

"By Issuer's 401(k) Plan Trustee"

A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.

stock option financial

"Stock option award granted under the issuer's incentive compensation plan."

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did CL grant to COO Panagiotis Tsourapas on September 16, 2026?

On September 16, 2026, he received 31,814 stock options with a $87.02 exercise price, expiring September 16, 2036, and a restricted stock unit award of 4,597 units of common stock, both granted under Colgate-Palmolive’s incentive compensation plan.

How do the new restricted stock units for CL’s COO vest?

The 4,597 restricted stock units granted to Colgate-Palmolive’s COO vest in three equal one-third installments on each of the first, second and third anniversaries of the September 16, 2026 grant date.

What are the key terms of the new stock options granted by CL to its COO?

The COO received 31,814 stock options to buy Colgate-Palmolive common stock at an exercise price of $87.02 per share. These options expire on September 16, 2036 and become exercisable in one-third increments starting on the first anniversary of the grant date.

What is the COO’s direct share ownership in CL after these awards?

After the reported awards, Colgate-Palmolive’s COO directly holds 11,447 shares of common stock. This figure reflects his direct ownership position following the September 16, 2026 grants.

What indirect holdings in CL stock does the COO have?

In addition to direct holdings, the COO has 4,619 shares of common stock held through the issuer’s 401(k) plan trustee and 64,901 shares held indirectly through a trust, as reported on the same date.

Were the CL insider transactions made under a Rule 10b5-1 trading plan?

No. The filing indicates that no Rule 10b5-1 trading plan is associated with these reported equity awards to the Colgate-Palmolive COO.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/18/2026 - 04:11 PM Accepted by SEC EDGAR 09/18/2026 - 04:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tsourapas Panagiotis

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NEW YORK 10022

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	COO, CD, EMEA, APac, Skin

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/16/2026		A(1)		4,597	A	$0.0000	11,447	D
Common Stock								4,619	I	By Issuer's 401(k) Plan Trustee
Common Stock								64,901	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$87.02	09/16/2026		A(2)		31,814		(3)	09/16/2036	Common Stock	31,814	$0.0000	31,814	D

Explanation of Responses:

1. Restricted stock unit award granted under the issuer's incentive compensation plan. The restricted stock unit award vests in equal 1/3 installments on each of the first, second and third anniversary of the date of grant.

2. Stock option award granted under the issuer's incentive compensation plan.

3. Option becomes exercisable in one-third increments beginning on the first anniversary of the September 16, 2026 grant date.

	/s/ Kristine Hutchinson, Attorney-in-Fact	09/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)